Laureate Secures Biopharma Deal

Contract biologics firm Laureate Pharma (Princeton, NJ) says it has received a biopharma manufacturing contract from Trubion Pharmaceuticals (Seattle) to produce its Tru-016 protein for preclinical and clinical testing. Tru-016 is a drug candidate for treating non-Hodgkins lymphoma and chronic lymphocytic leukemia. Financial terms were not...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers